Results 101 to 110 of about 25,524 (191)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults.

, 2011
There is no parenteral formulation of the neuraminidase inhibitor oseltamivir, the most widely used anti-influenza virus drug. Oseltamivir resistance is an increasing problem.
Sasithon Pukrittayakamee, Wattana Leowattana, Chueasuwanchai, S, Sunee Chueasuwanchai, Pukrittayakamee, S, Pratap Singhasivanon, Permpunpanich, S, Hanpithakpong, W, Sutatip Permpunpanich, Pan-Ngum, W, Fukuda, C, Warunee Hanpithakpong, Salwaluk Panapipat, Leowattana, W, Panapipat, S, Singhasivanon, P, Nicholas P. J. Day, Podjanee Jittamala, Caroline Fukuda, Aphiradee Phakdeeraj, Stepniewska, K, Nicholas J. White, Day, Nicholas, Lindegardh, N, Kasia Stepniewska, Wirichada Pan-Ngum, Phakdeeraj, A, White, Nicholas, Niklas Lindegardh, Jittamala, P   +29 more
core   +1 more source

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010

, 2011
Oseltamivir has been widely used for pandemic (H1N1) 2009 virus infection, and by April 30, 2010, a total of 285 resistant cases were reported worldwide, including 45 in the United Kingdom.
Laurence Calatayud, Angie Lackenby, Arlene Reynolds, Jim McMenamin, Maria Zambon, Nick F. Phin, Richard G. Pebody, Maria C. Zambon, Richard Pebody   +8 more
core   +1 more source

OSELTAMIVIR IN PEDIATRIC PRACTICES (WORLD'S APPLICATION EXPERIENCE)

, 2008
The authors analyzed the literature data on oseltamivir application for the flu prevention and treatment in pediatrics, which is most important for the practitioners.
A.V. Kharchev, A.S. Kolbin, A.B. Ivanyuk
core  

Impact of Oseltamivir and Diabetes Development

Background/Objectives: Influenza is a major global health challenge, causing thousands of deaths annually. Antiviral drugs, particularly oseltamivir, a neuraminidase inhibitor, have become essential therapeutic options due to their oral bioavailability ...
Pei-Hua Chuang, Pei-Hsun Wu, Tsai-Ching Hsu, Yu-Chun Pan, Chih-Chen Tzang, Bor-Show Tzang, I-Ying Kuo   +6 more
core   +1 more source

Clinical Use of Tamiflu (Oseltamivir) [PDF]

, 2008
Oseltamivir (Tamiflu, the trade name) is a neuraminidase inhibitor used for the treatment and prevention of influenza virus infection as well as those of avian influenza infection.
장미수, 우준희
core  

Oseltamivir [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

Oseltamivir in seasonal influenza: Cumulative experience in lowand high-risk patients

, 2010
Seasonal influenza viruses cause annual disease epidemics that affect individuals at low and high risk for secondary illnesses. Influenza vaccines are widely used in high-risk patients to prevent infection, but the protection afforded varies by ...
Regina Dutkowski
core  

Efficacy and safety of Lianhua Qingwen versus oseltamivir in children with influenza: a multicenter, randomized, double-blind, positive parallel-controlled study. [PDF]

Pharm Biol
Xue F, Li J, Hu S, Zhong C, Feng Z, Chen Z, Zhang B, Ma C, Geng S, Ren X, Jia Z, Xu B, Shen K, Ma R.   +13 more
europepmc   +1 more source

Characterizing Oseltamivir Use Among Community-Dwelling Patients Diagnosed With Influenza Virus Infection, 2023-2025. [PDF]

Open Forum Infect Dis
McNair EA, Kwon JH, Grijalva CG, McLaren SH, Biddle JE, Dean S, Bristol L, White EB, Fritz SA, Presti RM, O'Neil CA, Sano E, Vargas C, Schmitz J, Zhu Y, Scott TA, House S, Talbot HK, Stockwell MS, Mellis AM.   +19 more
europepmc   +1 more source

Oseltamivir and Influenza Treatment

, 2018
In patients with influenza, how does the addition of Oseltamivir in comparison to solely rest and fluids affect the length of the symptoms: fever, nausea, and ...
Kayla M. Romatowski
core